Licenses and Documents Needed to Launch a Derma Brand in India (Drug License, Trademark, GST, FSSAI vs CDSCO)

Licenses and Documents Needed to Launch a Derma Brand in India (Drug License, Trademark, GST, FSSAI vs CDSCO)

Most people researching how to start derma company India assume the hardest part will be finding the right manufacturer. It usually isn't. The genuinely time-consuming part is figuring out which registrations actually apply to a topical dermatology product, and in what order to chase them down.

This blog post isn't legal advice. You can think of it as a practical map of what typically needs to be in place before a derma brand can legally sell in the Indian market.

The Manufacturer Is Rarely the Hard Part

Dermatology products occupy an awkward middle ground between two very different regulatory worlds. Some are treated as cosmetics, some as OTC drugs, and where a product lands depends on its active ingredient and the claims printed on the label.

The distinction decides which regulator you're actually answering to, and it's exactly where most of the early confusion starts. A moisturising cream with no medicinal claim gets regulated very differently from an antifungal cream with a listed active, even though the two might sit side by side on a shelf looking almost identical.

Drug Licence (Wholesale or Loan Licence)

If a product contains a pharmaceutical active such as antifungals, antibacterials, corticosteroids, or similar ingredients, it falls under drug regulation rather than cosmetics regulation.

Brands that don't manufacture in-house typically operate under a loan licence arrangement, where the brand holds marketing rights while the actual production happens at an already-licensed third-party facility.

This is the standard structure behind most third-party manufacturing relationships in the derma space, and it's worth confirming with your manufacturer exactly how they handle this documentation on their end before anything gets signed.

Trademark Registration

Registering a trademark isn't legally required before you start selling, but skipping it is one of the more common regrets founders bring up later, usually once it's already too late to fix cheaply.

Registering the brand name and logo early protects it from being used or registered by someone else first, and it becomes considerably harder to secure once a brand has built up visible market presence without that protection already in place.

GST Registration

This one's fairly mechanical by comparison—a standard requirement for any commercial entity selling goods in India, and it needs to be in place before invoicing distributors, retailers or e-commerce platforms.

It's usually the more straightforward item on this checklist, but it still can't be skipped once actual sales begin.

FSSAI or CDSCO: Sorting Out Which One You Need

This is where most of the confusion concentrates, so it's worth being blunt about it. CDSCO, the Central Drugs Standard Control Organisation, governs products classified as drugs, which includes anything carrying a therapeutic active and a medicinal claim: antifungal creams, medicated soaps with active ingredients, minoxidil solutions, and similar products.

FSSAI, the Food Safety and Standards Authority of India, governs food and certain ingestible products, and it becomes relevant for a derma brand mainly if the range extends into categories like mouthwash or oral care products that involve the oral cavity in a way that's regulated under that framework.

The practical takeaway is simpler than the regulatory language suggests: most core derma products, such as creams, ointments, gels, lotions, and medicated soaps, sit under drug regulation and CDSCO's framework via the relevant state licensing authority, not FSSAI. FSSAI only becomes relevant once your range crosses into oral care or ingestible categories, and even then, the specific product decides which framework actually applies rather than the category as a whole.

What Changes When You Manufacture Through a Third Party

Working with an established third-party manufacturer changes this timeline in a meaningful way. A facility that is already WHO-GMP certified and holds its own manufacturing licenses has already cleared the production-side regulatory burden.

Your brand does not need to build a factory or hold a manufacturing license to sell under your own name. You still need your own loan license documentation, a trademark, and GST registration on the brand side, while the manufacturing compliance itself stays with the facility producing the product.

This is exactly the kind of structuring conversation worth having early rather than late. You can begin directly through Alister Life Sciences' third-party manufacturing page, or simply request a quote once you have a clearer picture of your product range. This lets the documentation conversation run alongside the formulation process instead of after it.

It also helps to keep a simple internal tracker showing which documents belong to the brand entity and which belong to the manufacturing facility. Founders occasionally assume a manufacturer's certifications cover their own marketing obligations. They do not. A facility's WHO-GMP status or drug manufacturing license speaks to how the product is made, but it says nothing about whether your brand name, trademark, or GST filings are in order on the commercial side. Keeping the two tracks separate in your planning avoids a common mix-up later.

A Sequence That Saves You From Redoing Work

There's no single legally mandated order to follow, but a practical sequence that avoids backtracking tends to look like this. Start by finalising your product category and confirming whether it falls under drug or cosmetic regulation, since almost everything downstream depends on getting this right first.

Register your business entity and apply for GST registration next. Begin the loan licence documentation process alongside your manufacturer around the same time, since this typically needs their existing licence details to move forward.

File your trademark application early too. It can run in parallel with manufacturing setup instead of waiting until the product is ready to launch. Only confirm FSSAI applicability if your range includes oral care or ingestible products, since it doesn't apply to most core derma formats.

Founders who try to finalise branding, packaging and marketing before locking in this documentation often end up reworking labels or claims once the licensing reality becomes clear. It genuinely pays to start this sequence early rather than treating it as something to sort out once the product itself is ready.

Ready to launch your derma brand seamlessly? Partner with Alister Life Sciences today for expert third-party manufacturing and regulatory guidance.

Related Articles

FAQs

Q.1. What is a loan licence in third-party manufacturing?
A: It's an arrangement where the brand holds marketing rights while an already-licensed manufacturer produces the product under their facility licence.
Q.2. Is WHO-GMP certification the same as a drug licence?
A: No, they're different. WHO-GMP certifies manufacturing quality standards, while a drug licence is a separate regulatory approval to manufacture or market the product.
Q.3. Does the manufacturer help with loan licence documentation?
A: Established manufacturers typically guide brands through this process since it involves their existing facility licence details.
Get Catalogue
Wp icon